GOT A REPLY....Same as we already have known but we got some comment. See below

Dear Tony:

Thank you for your email. I understand the concern of shareholders about the lack of current information. As mentioned in the Letter to Shareholders of March 3, 2009, we are diligently engaged in pursuing funding to complete the product development, obtain FDA clearance and transition to manufacturing and marketing.

As soon as we can release meaningful information we will do so.

Best regards

Stan